Literature DB >> 9628300

Endothelin-1, atrial natriuretic peptide and pathophysiology of pulmonary hypertension in porcine meconium aspiration.

H Soukka1, J Jalonen, P Kero, P Kääpä.   

Abstract

To evaluate the role of endothelin-1 (ET-1) and atrial natriuretic peptide (ANP) in the development of meconium aspiration-induced pulmonary hypertension, plasma ET-1 and ANP levels were measured serially for 6h after meconium instillation in juvenile pigs. Eleven 10-week-old, anaesthetized and catheterized pigs received intratracheally a bolus of 3 ml kg(-1) 20% human meconium, and five of them were premedicated with 30 mg kg(-1) methylprednisolone i.v. Another six pigs served as controls and were given 3 ml kg(-1) sterile saline intratracheally. Meconium instillation resulted in an increase in plasma ET-1 levels with a significant correlation to the simultaneously increasing PVR (r = 0.72). Methylprednisolone had no effect on the early (0-1 h) ET-1 increase, but prevented significantly the second phase (1-6 h) rise with a concomitant attenuation of the progressive pulmonary hypertension. ANP concentrations were higher in the meconium than in the control group throughout the study and further increased after steroid treatment with a good correlation to ET-1 (r = 0.86). Thus, the postinjury rise in circulating vasoactive peptides, together with the pulmonary hypertensive response, and modulation of the peptide balance and pressor reaction by steroids, suggest a contributory role for ET-1 and ANP in the development of pulmonary hypertension after meconium aspiration.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9628300     DOI: 10.1080/08035259850157039

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  7 in total

Review 1.  Surfactant for meconium aspiration syndrome in term and late preterm infants.

Authors:  Amr I El Shahed; Peter A Dargaville; Arne Ohlsson; Roger Soll
Journal:  Cochrane Database Syst Rev       Date:  2014-12-14

Review 2.  Pharmacologic strategies in neonatal pulmonary hypertension other than nitric oxide.

Authors:  Satyan Lakshminrusimha; Bobby Mathew; Corinne L Leach
Journal:  Semin Perinatol       Date:  2016-01-14       Impact factor: 3.300

Review 3.  Advances in the diagnosis and management of persistent pulmonary hypertension of the newborn.

Authors:  G Ganesh Konduri; U Olivia Kim
Journal:  Pediatr Clin North Am       Date:  2009-06       Impact factor: 3.278

4.  Persistent pulmonary hypertension of non cardiac cause in a neonatal intensive care unit.

Authors:  Gustavo Rocha; Maria João Baptista; Hercília Guimarães
Journal:  Pulm Med       Date:  2012-05-09

Review 5.  Glucocorticoids in the treatment of neonatal meconium aspiration syndrome.

Authors:  Daniela Mokra; Juraj Mokry
Journal:  Eur J Pediatr       Date:  2011-04-06       Impact factor: 3.183

6.  Persistent pulmonary hypertension of the newborn.

Authors:  Vinay Sharma; Sara Berkelhamer; Satyan Lakshminrusimha
Journal:  Matern Health Neonatol Perinatol       Date:  2015-06-03

7.  Risk factors and outcomes of persistent pulmonary hypertension of the newborn in neonatal intensive care unit of Al-minya university hospital in egypt.

Authors:  Abdel Hakeem Abdel Mohsen; Amr Salah Amin
Journal:  J Clin Neonatol       Date:  2013-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.